Help us: Donate
Follow us on:
×

Tag: Ending Age-Related Diseases 2019

August 26, 2020
Dr. Kelsey Moody is the CEO of Ichor Therapeutics, a company devoted to studying and curing the root causes of aging. Its research team consists of other 50 people in Lafayette, PA and continues to produce cutting-edge aging research. In his biotechnology workshop conducted at Ending Age-Related Diseases 2019 and made available at Ending Age-Related...
January 17, 2020
We're releasing yet another talk from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. This talk is from Amutha Boominathan of SENS Research Foundation, who discussed her work with mitochondria - some of which...
November 28, 2019
Aimed at people who aren't familiar with our annual Ending Age-Related Diseases conference, this video showcases this year's speakers, getting their thoughts and perspectives on where we are now and what can be done about aging in the future. (adsbygoogle = window.adsbygoogle || []).push({});
November 05, 2019
This is the final talk that we are releasing from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. João Pedro de Magalhães of the University of Liverpool discussed the genetic basis of aging and...
November 01, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Sree Kant of Life Biosciences discussed investment and R&D in an aging world, demonstrating the necessity of rejuvenation biotechnology in...
October 29, 2019
We're continuing to release talks from Ending Age-Related Diseases 2019, our highly successful two-day conference that featured talks from leading researchers and investors, bringing them together to discuss the future of aging and rejuvenation biotechnology. Kevin Strange discussed his company, Novo Biosciences, and how it is developing small molecules that restore the body's ability to...